Feedback / Questions
Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
Potential uric acid-lowering effect of sacubitril/valsartan.
(PubMed, Hypertens Res)
-
Oct 19, 2026 -
No abstract available
Journal
•
Cardiovascular • Hypertension
http://www.ncbi.nlm.nih.gov/pubmed/42894030
Shunichiro Tsukamoto
Oct 19, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next